Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00800267 · ClinicalTrials.gov registry record · Phase 3
A Study of Glaucoma or Ocular Hypertension in Patients Within the United States
A Phase 3 study, sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris.
- Completed
- Registry status
- Phase 3
- Development phase
- 418
- Enrollment target
NCT00800267: Completed Phase 3 study, sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris.
NCT00800267 is a Phase 3 study that has completed, run by Pfizer's Upjohn has merged with Mylan to form Viatris. The registered enrollment target is 418 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (46% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00800267, a Phase 3 study, has completed, sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 418 participants
- Enrollment target
Study Summary
Safety and efficacy study comparing between fixed combination latanoprost-timolol and its component parts.
Interventions
- DRUG latanoprost 0.005%
- DRUG timolol 0.5%
- DRUG fixed combination latanoprost-timolol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 418 participants |
| Start Date | 1997-07 |
| Est. Completion | 1999-06 |
| Phase | Phase 3 |
What the finished NCT00800267 record still lists
NCT00800267 is an interventional study that assigns participants to a tested intervention. The registered 418 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (46% lower).
The record links to 0 conditions, and to 3 interventions - of which latanoprost 0.005% is the first listed.
NCT00800267 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00800267 about?
NCT00800267 is a clinical study titled "A Study of Glaucoma or Ocular Hypertension in Patients Within the United States". Safety and efficacy study comparing between fixed combination latanoprost-timolol and its component parts.
What is the current status of trial NCT00800267?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 418 participants. The study started on 1997-07. Estimated completion is 1999-06.
What interventions are being tested in trial NCT00800267?
The interventions under investigation include: latanoprost 0.005% (DRUG), timolol 0.5% (DRUG), fixed combination latanoprost-timolol (DRUG).
Who is sponsoring clinical trial NCT00800267?
This trial is sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00800267's enrollment target sits among peer trials
418 900th of 2000 higher than 1,099 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03135886 · 418 participants · NA
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
- NCT05579639 · 419 participants · Phase 2
Xylitol BSI Multisite - Reduction of Bloodstream Infections From Oral Organisms in Pediatric Stem Cell Transplant
- NCT06169735 · 417 participants · Phase 4
Does Fluorescence With or Without Indocyanine Green Improve Parathyroid Identification and Preservation
- NCT06699901 · 417 participants
Antibiotic Concentrations After MassivE Transfusion Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia